Stem cell treatment of Multiple Sclerosis

Multiple Sclerosis

Multiple sclerosis (MS) is a chronic neurological disorder that affects the central nervous system (brain and spinal cord). The disease process results in inflammation and damage to myelin (the insulating tissue for nerve fibers) and other cells within the nervous system.

Because myelin aids the conduction of nerve signals, damage to myelin results in impaired nerve signaling and may impair normal sensation, movement, and thinking. This damage occurs in patches that appear as distinct lesions on magnetic resonance imaging (MRI). The patches cause different symptoms, depending on their location within the nervous system.

The XCell-Center Multiple Sclerosis treatment

The stem cells are first collected from a patient's bone marrow, extracted from the hipbone (iliac crest) then implanted back into the body days later. Prior to re-implantation of the cells, the bone marrow is processed in one of our labs, where the quantity and quality of the stem cells is also checked.

These re-injected stem cells have the potential to transform into multiple types of cells and are capable of regenerating damaged tissue. Our innovative stem cell treatments use the self-healing potential of each patient's own body to stimulate regeneration or repair.

Currently there is no cure for MS. There are treatments available that may slow its progression and alleviate associated symptoms. Stem cell therapy is among these treatment options.

Results

In the bar chart below you can see the results of a survey of 19 of our multiple sclerosis patients. The survey was conducted one to six months after the treatment. Results from Multiple Sclerosis treatment after 1-6 months

  • Seven out of 19 patients reported no change in spasticity, sensation, mobility or feeling of well-being after the treatment.
  • Eight out of 19 patients reported an improvement, with reduced spasticity and/or improved sensation and/or improved mobility and/or a reduction in fatigue.
  • Three out of 19 patients reported a strong improvement, with an absence of spasticity and/or a marked improvement of sensation and/or marked improvement in mobility. They also reported improved bladder control and/or better vision and/or a marked reduction of fatigue.
  • One patient reported a perceived deterioration of the quality of his life. The treatment could neither stop nor reverse the advance of the MS symptoms.

Cost

The price for the intrathecal treatment is 7,545 Euros.
Under a local anesthetic, your stem cells will be injected directly into the cerebrospinal fluid via lumbar puncture.

Request information and receive a brochure to learn more about our multiple sclerosis stem cell treatment.

News
  • Stem cells and tumor risk more…
  • November 18, 2009
    Our 2009 Patient Satisfaction Survey Results are in! more…
  • July 20, 2009
    Safety Follow-up in 350 patients after stem cell therapy more…
  • June 8, 2009
    Autologous stem cell therapy for autism - a letter to President Obama more…
  • February 25, 2009
    Stem Cell Heart Treatment Unveiled at the XCell-Center more…
  • January 20, 2009
    XCell-Center inaugurates second institute for stem cell transplantation in Düsseldorf more…
  • TV Link: About XCell-Center more…
  • News archive 2008 more…
  • News archive 2007 more…